Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer.

Cells · 2019 · PMC6406838 · PMID 30781493

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Reduced RNF20 expression and the concomitant reduction in H2BK120ub1 levels are known to activate the expression of key proto-oncogenes (e.g., MYC and FOS ) and, therefore, may be significant drivers of oncogenesis [ 17 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.